Drug Trial Radar · NCT06118866
A Study to Assess the Efficacy and Safety of HMI-115 in Male Subjects With Androgenetic Alopecia
Last checked: Nov 19, 2026Latest source record: Jun 4, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
192
Actual
Start
Sep 11, 2023
Primary completion
Aug 26, 2024
Study completion Nov 28, 2024
Sponsor
- Lead sponsor
- Hope Medicine (Nanjing) Co., LtdIndustry
- Sponsor type
- Industry
- First posted
- Nov 7, 2023
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- Male only, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To investigate the efficacy of HMI-115 compared to placebo in treating Androgenic Alopecia patients for 24 weeks
Conditions
- Androgenetic Alopecia
Interventions
placebo-Q2WDrug
placebo, 0mg,SC,Q2W,12 cycles
HMI-115-120mg-Q4WDrug
HMI-115, 120mg,SC,Q4W,6 cycles(Placebo given in the second week of each cycle)
HMI-115-240mg-Q4WDrug
HMI-115, 240mg,SC,Q4W,6 cycles(Placebo given in the second week of each cycle)
HMI-115, 240mg-Q2WDrug
HMI-115, 240mg,SC,Q2W,12 cycles
Primary outcomes
What the sponsor says the trial is designed to measure.
- The Rate of Target Arean Hair Count (TAHC)Time frame: 24 Weeks
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Peking University People's Hospital
Beijing, Beijing Municipality, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.